Výsledky vyhledávání - Lasseter, Kenneth
- Zobrazuji výsledky 1 - 20 z 22
- Přejít na další stránku
-
1
Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate... Autor Ermer, James, Corcoran, Mary, Lasseter, Kenneth, Martin, Patrick T.
Vydáno 2016Text -
2
Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis Autor Zomorodi, Katie, Chen, Dan, Lee, Lawrence, Lasseter, Kenneth, Marbury, Thomas
Vydáno 2019Text -
3
-
4
-
5
-
6
A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function Autor Ermer, James, Corcoran, Mary, Lasseter, Kenneth, Marbury, Thomas, Yan, Brian, Martin, Patrick T.
Vydáno 2016Text -
7
Pharmacokinetics and Tolerability of a Single Dose of Semaglutide, a Human Glucagon-Like Peptide-1 Analog, in Subjects With and Without Renal Impairment Autor Marbury, Thomas C., Flint, Anne, Jacobsen, Jacob B., Derving Karsbøl, Julie, Lasseter, Kenneth
Vydáno 2017Text -
8
Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment Autor Schultze‐Mosgau, Marcus‐Hillert, Lasseter, Kenneth C., Marbury, Thomas, Loewen, Stephanie, Riecke, Kai
Vydáno 2020Text -
9
Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults Autor Ermer, James, Haffey, Mary B, Richards, Cynthia, Lasseter, Kenneth, Adeyi, Ben, Corcoran, Mary, Stanton, Beverly, Martin, Patrick
Vydáno 2013Text -
10
An Open-Label Investigation of the Pharmacokinetic Profiles of Lisdexamfetamine Dimesylate and Venlafaxine Extended-Release, Administered Alone and in Combination, in Healthy Adult... Autor Ermer, James, Haffey, Mary B., Richards, Cynthia, Lasseter, Kenneth, Roesch, Benno, Purkayastha, Jaideep, Corcoran, Mary, Harlin, Bree, Martin, Patrick
Vydáno 2013Text -
11
Pharmacokinetic Interactions Between Isavuconazole and the Drug Transporter Substrates Atorvastatin, Digoxin, Metformin, and Methotrexate in Healthy Subjects Autor Yamazaki, Takao, Desai, Amit, Goldwater, Ronald, Han, David, Lasseter, Kenneth C., Howieson, Corrie, Akhtar, Shahzad, Kowalski, Donna, Lademacher, Christopher, Rammelsberg, Diane, Townsend, Robert
Vydáno 2016Text -
12
The Influence of Hepatic and Renal Impairment on the Pharmacokinetics of a Treatment for Herpes Zoster, Amenamevir (ASP2151): Phase 1, Open-Label, Single-Dose, Parallel-Group Studi... Autor Kusawake, Tomohiro, Kowalski, Donna, Takada, Akitsugu, Kato, Kota, Katashima, Masataka, Keirns, James J., Lewand, Michaelene, Lasseter, Kenneth C., Marbury, Thomas C., Preston, Richard A.
Vydáno 2017Text -
13
Pharmacokinetic Evaluation of CYP3A4‐Mediated Drug‐Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults... Autor Townsend, Robert, Dietz, Albert, Hale, Christine, Akhtar, Shahzad, Kowalski, Donna, Lademacher, Christopher, Lasseter, Kenneth, Pearlman, Helene, Rammelsberg, Diane, Schmitt‐Hoffmann, Anne, Yamazaki, Takao, Desai, Amit
Vydáno 2016Text -
14
Effect of Mild and Moderate Hepatic Impairment (Defined by Child–Pugh Classification and National Cancer Institute Organ Dysfunction Working Group Criteria) on Pexidartinib Pharmac... Autor Zahir, Hamim, Greenberg, Jonathan, Hsu, Ching, Marbury, Thomas C., Lasseter, Kenneth C., Xu, Li‐An, Tap, William D., Healey, John H., Stacchiotti, Silvia, LaCreta, Frank
Vydáno 2022Text -
15
Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD‐6972 in healthy subjects and subjects with type 2 diabetes mellitus Autor Vajda, Eric G., Logan, Douglas, Lasseter, Kenneth, Armas, Danielle, Plotkin, Diane J., Pipkin, JD, Li, Yong-Xi, Zhou, Rong, Klein, David, Wei, Xiaoxiong, Dilzer, Stacy, Zhi, Lin, Marschke, Keith B.
Vydáno 2016Text -
16
Lack of a Significant Drug Interaction between Raltegravir and Tenofovir Autor Wenning, Larissa A., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Stek, Jon E., Lasseter, Kenneth C., Gottesdiener, Keith M., Chen, Joshua, Teppler, Hedy, Wagner, John A., Stone, Julie A., Iwamoto, Marian
Vydáno 2008Text -
17
Lack of a Clinically Important Effect of Moderate Hepatic Insufficiency and Severe Renal Insufficiency on Raltegravir Pharmacokinetics Autor Iwamoto, Marian, Hanley, William D., Petry, Amelia S., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Lasseter, Kenneth C., Robson, Richard, Lunde, Norman M., Wenning, Larissa A., Stone, Julie A., Wagner, John A.
Vydáno 2009Text -
18
Impact of renal impairment and human organic anion transporter inhibition on pharmacokinetics, safety and tolerability of relebactam combined with imipenem and cilastatin Autor Bhagunde, Pratik, Colon‐Gonzalez, Francheska, Liu, Yang, Wu, Jin, Xu, Shiyao Sherrie, Garrett, Graigory, Jumes, Patricia, Lasseter, Kenneth, Marbury, Thomas, Rizk, Matthew L., Lala, Mallika, Rhee, Elizabeth G., Butterton, Joan R., Boundy, Keith
Vydáno 2020Text -
19
Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics – results from single oral dose studies in healthy... Autor Stoch, S Aubrey, Zajic, Stefan, Stone, Julie A, Miller, Deborah L, Bortel, Lucas, Lasseter, Kenneth C, Pramanik, Barnali, Cilissen, Caroline, Liu, Qi, Liu, Lida, Scott, Boyd B, Panebianco, Deborah, Ding, Yu, Gottesdiener, Keith, Wagner, John A
Vydáno 2013Text -
20
Potential for Interactions between Caspofungin and Nelfinavir or Rifampin Autor Stone, Julie A., Migoya, Elizabeth M., Hickey, Lisa, Winchell, Gregory A., Deutsch, Paul J., Ghosh, Kalyan, Freeman, Amanda, Bi, Sheng, Desai, Rajesh, Dilzer, Stacy C., Lasseter, Kenneth C., Kraft, Walter K., Greenberg, Howard, Waldman, Scott A.
Vydáno 2004Text